Gene Therapy Company bluebird bio (BLUE) Files $86M IPO

May 14, 2013 5:49 PM EDT Send to a Friend
Cambridge-based bluebird bio (Nasdaq: BLUE) filed a $86.25 million IPO Tuesday evening. The company plans to list on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login